Clinical Study
Clinical Significance and Prognostic Impact of Subcutaneous or Intrastrap Muscular Recurrence of Papillary Thyroid Carcinoma
Table 1
Backgrounds and clinical features at initial surgery that were preoperatively evaluated for 29 PTC patients showing SIM recurrence.
| Gender | | | Male | 5 (17%) | | Female | 24 (832) | | Age (yrs) | | | ≥55 | 24 (83%) | | <55 | 5 (17%) | | Family history of PTC | | | Yes | 0 | | No | 29 (100%) | | Size of primary lesions (cm) | | | >4 | 3 (11%) | | 2.1−4 | 17 (65%) | | 1.1−2 | 5 (20%) | | ≤1 | 1 (4%) | (3 unknown) | Clinical node metastasis () | | | N1b | 11 (42%) | | N1a | 1 (4%) | | N0 | 14 (54%) | (3 unknown) | Lymph node metastasis ≥3 cm | | | Yes | 4 (15%) | | No | 22 (85%) | (3 unknown) | Stage | | | IVA | 10 (38%) | | III | 1 (4%) | | II | 11 (42%) | | I | 4 (15%) | (3 unknown) | Multiplicity on imaging studies | | | Multiple | 6 (23%) | | Solitary | 20 (77%) | (3 unknown) |
|
|